METHOD OF TREATMENT OF PERACUTE, CHRONIC AND SUBACUTE COUGH AND IRRESISTIBLE DESIRE TO CLEAR THROAT Russian patent published in 2018 - IPC C07D239/48 A61K31/505 A61P11/14 

Abstract RU 2650118 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to method of treating chronic cough such as idiopathic or treatment resistant cough, method for reducing neuronal hypersensitivity underlying acute, subacute or chronic cough, and method for treating cough or irresistible desire to clear throat associated with respiratory disease. Each of these methods comprises administering an effective amount of compound of formula (I) (I) or a pharmaceutically acceptable salt thereof. In the compounds of formula (I), R1 is hydrogen or optionally substituted with halogen atoms C1-C6alkyl, propynyl, and R2 denotes C1-C6alkyl; C2-C6alkenyl; amino; aminosulfonyl; C1-C6alkylaminosulfonyl; halogen; amide selected from aminocarbonyl, di(C1-C6alkyl)aminocarbonyl, aminocarbonylamino, C1-C6alkylcarbonylamino or C1-C6alkylaminocarbonylamino, phenylaminocarbonylamino, carbonylamino; haloC1-C6alkyl; C1-C6alkoxy; haloC1-C6alkoxy; nitro; oxy-C1-C6-alkyl; C1-C6-alkoxyC1-C6alkyl; C1-C6alkylsulfonyl; cyano or C1-C6alkylcarbonyl. Compound has the properties of a P2X3 receptor antagonist and / or a P2X2 / 3. Preferably, the compound of formula (I) is administered in an amount of about 600 mg twice daily for about 2 weeks. Compounds are also suitable for the treatment of persistent chronic or daytime cough. In this case, the cough can decrease by about 75 %. Invention also relates to use of compound of formula (I) or pharmaceutically acceptable salt thereof for the preparation of medicament for the treatment of chronic cough, or cough treatment and irresistible desire to clear throat associated with respiratory disease, or to treat the hypersensitivity of neurons underlying peraacute, subacute or chronic cough.

EFFECT: invention also relates to medicament for said use comprising, as active ingredient, compound of formula (I) or pharmaceutically acceptable salt thereof.

30 cl, 1 dwg, 2 tbl, 30 ex

Similar patents RU2650118C2

Title Year Author Number
DIAMINOPYRIMIDINES AS P2X RECEPTOR ANTAGONISTS 2005
  • Karter Dejvid Skott
  • Dillon Majkl Patrik
  • Kholej Ronald Charlz
  • Lin Klara Chou Chzhen
  • Parish Daniel Uorren
  • Broka Kris Allen
  • Jakhangir Alam
RU2422441C2
NEW METHOD FOR SYNTHESIS OF PHENOXYDIAMINOPYRIMIDINE COMPOUND 2019
  • Melouni, Kevin, M.
  • Basu, Kellol
  • Chung, Dzhon, J.L.
  • Desmond, Richard
  • Di Maso, Majkl Dzhejms
  • Khamfri, Gaj, R.
  • Li, Alfred, J.
  • Lenerr, Dan
  • Pen, Fyn
  • Zhen, Khun
  • Vajzel, Mark
  • Chzhan, Syvej
  • Larpan, Patrik
RU2805661C2
DYETERED DIAMINOPYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH CONNECTIONS 2014
  • Lv Binkhua
  • Li Chenvej
  • Tsao Benven
  • Pan Syujdun
RU2632907C2
QUINAZOLINONE DERIVATIVES EFFECTIVE AS VANILLOID ANTAGONISTS 2005
  • Ritchi Timoti Dzhon
  • Kalsho Ehndr'Ju Dzhejms
  • Brejn Kristofer Tomas
  • Dzjadulevich Ehduard Karol
  • Khart Terens
RU2449995C2
QUINAZOLINE DERIVATIVES EFFECTIVE AS VANILOID ANTAGONISTS 2005
  • Ritchi Timoti Dzhon
  • Kalsho Ehndr'Ju Dzhejms
  • Brejn Kristofer Tomas
  • Dzjadulevich Ehduard Karol
  • Khart Terens
RU2396261C2
SUBSTITUTED AMINOINDANS AND ANALOGUES THEREOF TO BE USED IN PHARMACEUTICS 2009
  • Rakel'Mann Nil'S
  • Bjaly Loran
  • Ehnglert Genrikh
  • Virt Klaus
  • Arndt Petra
  • Uehston Dzhon
  • Khajnel'T Uve
  • Follmann Markus
RU2522586C2
SULFONAMIDES AND PHARMACEUTICAL PREPARATION 1995
  • Folker Broj
  • Kaspar Burri
  • Zhan-Mari Kassal'
  • Martin Klozel'
  • Zhorzh Khirt
  • Bernd-Mikhaehl' Leffler
  • Marsel' Mjuller
  • Verner Najdkhart
  • Khenri Ramuz
RU2162084C2
N4-PHENYLQUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS RECEPTOR TYROSINE KINASE TYPE ERBB INIHIBITORS FOR TREATING HYPERPROLIFERATIVE DISEASES 2006
  • Lissikatos Dzhozef P.
  • Marmsater Fredrik P.
  • Chao Chzhan'
  • Greschuk Dzhuli Mari
  • Vejdong L'Ju
  • Khennings Dehvid D.
RU2428421C2
NON-NUCLEOSIDE REVERSE TRANCRIPTASE INHIBITORS, USES THEREOF, PHARMACEUTICAL COMPOSITION FOR HIV INHIBITION 2004
  • Dann Dzhejms Patrik
  • Khogg Dzhoan Kheder
  • Mirzadegan Taranekh
  • Svolou Stiven
RU2305680C2
INHIBITORS OF TYPE ErbB INHIBITORS 2006
  • Lissikatos Dzhozef P.
  • Marmsater Fredrik P.
  • Chao Chzhan
  • Greschuk Dzhuli Mari
  • Vejdong Lyu
  • Khennings Devid D.
RU2592703C9

RU 2 650 118 C2

Authors

Ford Anthony P.

Mccarthy Bruce G.

Dates

2018-04-09Published

2014-08-22Filed